EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cutting to the core: Proteases in the tumor–bone interface and metastatic progression

Ridhi Bhola, Reegan Sturgeon, Rakesh K Singh

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-04 · 1881 (2) · 189567

DOI: 10.1016/j.bbcan.2026.189567 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-04. Verfasst von Ridhi Bhola und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, The University of Nebraska Medical Center, 985845 Nebraska Medical Center, Omaha, NE 68198-584…. Hauptthemen laut MEDLINE: Bone Neoplasms, Prostatic Neoplasms, Matrix Metalloproteinases, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteases are critical modulators of cancer progression, with matrix metalloproteinases (MMPs) and cathepsins playing central roles in the development and metastasis of breast and prostate cancers. These enzymes degrade and remodel the extracellular matrix, facilitating tumor-stromal interactions and promoting epithelial-to-mesenchymal transition, thereby enhancing tumor invasiveness. Beyond the primary tumor site, proteases contribute to multiple steps of the metastatic cascade, including intravasation, immune evasion, and extravasation. Importantly, MMPs and cathepsins also drive osteolytic activity that supports tumor colonization and growth in the bone microenvironment by activating osteoclasts, releasing matrix-bound growth factors, and perpetuating a vicious cycle of bone destruction. Given their multifaceted roles, MMPs and cathepsins represent promising therapeutic targets in bone-metastatic breast and prostate cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsProstatic NeoplasmsMatrix MetalloproteinasesBreast NeoplasmsCathepsinsHumansDisease ProgressionAnimalsTumor MicroenvironmentMaleFemaleEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Bone metastasisProteasesTumor progressionTumor-stromal interaction

Substanzen

Matrix MetalloproteinasesCathepsins

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, The University of Nebraska Medical Center, 985845 Nebraska Medical Center, Omaha, NE 68198-5845, United States of America.
  • Department of Pathology, Microbiology, and Immunology, The University of Nebraska Medical Center, 985845 Nebraska Medical Center, Omaha, NE 68198-5845, United States of America. Electronic address: RSINGH@UNMC.EDU.

Förderung

  • NCI NIH HHS
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Bhola, R., Sturgeon, R., & Singh, R. K. (2026). Cutting to the core: Proteases in the tumor–bone interface and metastatic progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(2), 189567. https://doi.org/10.1016/j.bbcan.2026.189567

Vancouver

Bhola R, Sturgeon R, Singh RK. Cutting to the core: Proteases in the tumor–bone interface and metastatic progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(2):189567. doi:10.1016/j.bbcan.2026.189567

BibTeX
@article{Bhola2026,
  author = {Bhola, Ridhi and Sturgeon, Reegan and Singh, Rakesh K},
  title = {Cutting to the core: Proteases in the tumor–bone interface and metastatic progression},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {2},
  pages = {189567},
  doi = {10.1016/j.bbcan.2026.189567}
}
Kostenlos starten →